Navigation Links
Berlin Heart Inc. Receives FDA Orphan Product Development Grant
Date:6/17/2009

he importance of our product and for the potential it has to make a life-saving difference for pediatric patients."

About EXCOR(R) Pediatric

The EXCOR Pediatric Ventricular Assist Device is a mechanical cardiac support system for critically ill pediatric patients suffering from severe heart failure. EXCOR Pediatric has been used in more than 500 pediatric patients worldwide ranging from newborns with 2.2 kg body weight to teenagers. EXCOR is currently under clinical investigation for pediatric patients in USA.

About Berlin Heart

Berlin Heart GmbH is the only company worldwide that develops, produces, and distributes implantable and external ventricular assist devices (also called mechanical heart support systems) for patients of every age and body size. The company is market leader in Germany and Europe.

The company also manufactures the implantable left ventricular assist device INCOR(R), which has been designed for long-term application in adult patients. The longest the device has supported a patient so far is more than five and a half years and ongoing. INCOR is not FDA approved, but widely used in Europe.

    Contact:
    Linda Buerk
    Manager Marketing & PR
    Phone: +49(0)30-8187-2650
    Mobile: +49(0)173-629-0803
    buerk@berlinheart.de

'/>"/>
SOURCE Berlin Heart GmbH
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. 500th Patient Receives Berlin Heart EXCOR Pediatric Ventricular Assist Device
2. DuoCort Hosts Adrenal Insufficiency Symposium at the 10th European Congress of Endocrinology in Berlin
3. Berlin Heart Enrolls First Patient in US Multi-Center EXCOR(R) Pediatric VAD IDE Study
4. PeriCor Therapeutics Reports Positive Preclinical Results of GP531 at the European Heart Failure Congress in Nice
5. Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial
6. Nile Therapeutics CD-NP Clinical Program for Acute Heart Failure Released From Clinical Hold by FDA
7. Boston Scientific to Donate Cardiac Rhythm Management Devices to Heartbeat International for Implantation in Needy Patients
8. Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions
9. deCODE and Celera Partner to Expand use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes
10. Thoratec Announces Filing of PMA Seeking Destination Therapy Approval for HeartMate II(R)
11. Symphony Medical Announces First Patient Successfully Treated With Novel Congestive Heart Failure Therapy

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...CellTherapeutics,Inc.(CTI)(NasdaqandMTA:CTIC)manag...areConference.TheconferencewillbeheldDecember1-2,2...nTuesday,December1at11:00a.m.EasternTimeinHolmes1(...beavailableat www.celltherapeutics.com ,anditwilla...yHealthCareConference,NewYorkPalaceHotel,Holmes1(4...
(Date:11/23/2009)...ication, computation and more powerful ways to enc...tum states as carriers of information is an extrem...wn, mathematically, how to gently tease out unwant...he information intact. Their work is reported in t...highlighted with a Viewpoint in Physics ( http:/...
(Date:11/23/2009)...Call/-YMBioSciencesInc.(NYSEAmex: YMI ;TSX:YM),ali...ndadvancesadiverseportfolioofpromisingcancer-relat...edthatCytopia(ASX:CYT)hascommencedenrollmentofaPha...teredJAK1/JAK2inhibitor.Thetrialisbeingconductedat...topiaintoYMhasbeenpreviouslyannouncedandispendinga...
(Date:11/23/2009)...gnC or p.(IDC)announcedtodaythatDr.BruceL.A.Carter...ssfultrackrec or dinbiotechnologyexecutivemanageme...tics,inSeattle,WAandChiefScientificOfficeratNovoN ...ww.newscom.com/cgi-bin/prnh/20091123/SF15228 ) ,...cercommented,"IamdelightedtowelcomeDr.BruceCartera...
Breaking Biology Technology:YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2
..., Produce PCR amplicons that are easily clon...se: ,A High-Performance, High-Fidelity Enzyme Id... ,Stratagene , A chloramphenicol resistance (C...e * , was cloned into the PCR-Script,vector ...olymerase not only creates high-fidelity products,...
..., Human Universal cDNA Library Array I ,,...ic acid screening , , Jean-Michel ... Sandra Soares , Stratagene , St...lones from a universal , cDNA library tha...tissues. , This normalized library demons...
..., Optimizing Transfection Conditions for Studyin...,,, Obtaining the best results with Pat...Tim Sanchez Li Xu Mary Buchanan Chao-Feng Zheng...n vivo signal transduction pathway reporting syste...aling pathways by uncharacterized gene products,...
Other Biology Technology:pfuturbo DNA Polymerase:,A High-Performance, High-Fidelity Enzyme Ideal for PCR Cloning 2pfuturbo DNA Polymerase:,A High-Performance, High-Fidelity Enzyme Ideal for PCR Cloning 3pfuturbo DNA Polymerase:,A High-Performance, High-Fidelity Enzyme Ideal for PCR Cloning 4Human Universal cDNA Library Array I 2Human Universal cDNA Library Array I 3Human Universal cDNA Library Array I 4Human Universal cDNA Library Array I 5Human Universal cDNA Library Array I 6Human Universal cDNA Library Array I 7Optimizing Transfection Conditions for Studying Signal Transduction Pathways 2Optimizing Transfection Conditions for Studying Signal Transduction Pathways 3Optimizing Transfection Conditions for Studying Signal Transduction Pathways 4Optimizing Transfection Conditions for Studying Signal Transduction Pathways 5Optimizing Transfection Conditions for Studying Signal Transduction Pathways 6Optimizing Transfection Conditions for Studying Signal Transduction Pathways 7
(Date:11/24/2009)... NEW YORK (November 24, 2009) -- The Wildlife Co...revealing that the last remaining population of Si...e to the rising tide of poaching and habitat loss....orm Russian officials of what needs to be done to ...st cat. , The report was released b...
(Date:11/24/2009)... is available in Spanish . , The presence o...of inflammatory substances in the blood, hinders t...y a research project of the University of Navarra ... at the School of Pharmacy. , The project, entit...tion to the control of body weight and inflammatio...
(Date:11/23/2009)...vember 23, 2009 - The time of day matters to fores...aper produced by a research team led by Professor ...h,s vice-principal for research and colleagues in ...St. George campus. , Capitalizing on their pre..., the research team examined how poplar trees use ...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2It can be predicted the reaction obese patients will have to a diet 2Time of day matters to thirsty trees, U of T researcher discovers 2My1Stop com Named 2009 Inc 500 5000 Honoree 56140 1My1Stop com Named 2009 Inc 500 5000 Honoree 56140 2FDA Study Indicates Most Industry Postmarketing Studies Meet Timelines 56136 1FDA Study Indicates Most Industry Postmarketing Studies Meet Timelines 56136 2FDA Study Indicates Most Industry Postmarketing Studies Meet Timelines 56136 3Photo 3A Poor Disabled Children in Ecuador Receive Free Wheelchairs 21 56135 1Photo 3A Poor Disabled Children in Ecuador Receive Free Wheelchairs 21 56135 2Photo 3A Poor Disabled Children in Ecuador Receive Free Wheelchairs 21 56135 3
...-- Cutting-edge breakthroughs in molecular targeti...ntion will take center stage when more than 17,000...n Diego Convention Center April 12-16 for the 2008...ncer Research (AACR). Key data presented at the me...ndings related to high-profile, potentially life-s...
... to be dead is an effective self-defense strategy ...m neighboring colonies. This tactic makes them fou...er workers who fight back. As a result, these youn... colony growth to ensure the survival and fitness ...sill from the Biology Department at USF Petersburg...
... Exhibitors Will Be Promoting BIO-key at This Year...rnational, Inc. (OTC Bulletin Board: BKYI), a lead...reless public safety solutions, announced,today th... products at the,2008 RSA Conference. This informa...nference Center from April 7th to April 11th in Sa...
Other Biology News:AACR annual meeting showcases developments in understanding and targeting cancers 2AACR annual meeting showcases developments in understanding and targeting cancers 3Playing dead is no game for ant survival 2BIO-key(R) to Showcase Biometric Identification Technology at 2008 RSA Conference 2
Concentrated Epitope Retrieval Buffer-Reduced pH from Bethyl Laboratories
GIBCO Calf Serum; Heat-Inactivated from Invitrogen
GIBCO Newborn Calf Serum; Heat-Inactivated from Invitrogen
...rotein Standards are specifically designed for eas...on directly on western blots. Each standard protei...sualization with the same antibody-conjugate reage...s. Colorimetric, chemiluminescent, or fluorescent ...
Biology Products: